Clinical Trials List
2017-03-01 - 2019-12-31
Phase III
Terminated6
ICD-10C50
Malignant neoplasm of breast
ICD-9174.0
Malignant neoplasm of female breast, nipple and areola
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 郭文宏 Division of General Surgery
- 林柏翰 Division of General Internal Medicine
- 羅喬 Division of General Surgery
- 林季宏 Division of Hematology & Oncology
- YEN-SHEN LU Division of Hematology & Oncology
- 蔡立威 Division of General Surgery
- MING-YANG WANG Division of General Surgery
- 楊雅雯 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Completed
Audit
None
Co-Principal Investigator
- Wei-Pang Chung Division of Hematology & Oncology
- Zhu-Jun Loh Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 褚乃銘 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- Chun-Yu Liu Division of Hematology & Oncology
- 金光亮 Division of General Surgery
- 邱仁輝 Division of General Surgery
- Yi-Fang Tsai Division of General Surgery
- 林燕淑 Division of General Surgery
- Ta-Chung Chao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
7 Completed
Audit
None
Taiwan National PI
Co-Principal Investigator
- Wen-Chi Shen Division of Hematology & Oncology
- 周旭桓 Division of General Surgery
- Chi-Chang Yu Division of General Surgery
- Mengting Peng Division of Hematology & Oncology
- Yung-Chang Lin Division of Hematology & Oncology
- Chan-Keng Yang Division of Hematology & Oncology
- 沈士哲 Division of General Surgery
- Wen-Ling Kuo Division of General Surgery
The Actual Total Number of Participants Enrolled
9 Completed
Audit
CRO
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
約50 participants
-
Global
約855 participants